Insights

Strategic Partnerships C3 has a history of collaborating with patient advocacy groups and organizations (NORD, MDA, Rare Disorders) to advance research and education. This presents an opening to propose collaborative grant opportunities, joint informational campaigns, and co-hosted events or webinars to accelerate study recruitment and awareness.

Clinical Research Focus With recent announcements of a global study on Calpainopathy and a gene therapy development initiative, there is a clear need for research infrastructure, data management, regulatory support, and clinical trial services. Offer CRO, GMP, regulatory affairs, and patient recruitment solutions tailored to rare diseases.

Funding Readiness Annual revenue under one million and active grant-funded projects suggest opportunities to assist with grant writing, grant management software, budgeting tools, and donor stewardship platforms to maximize funding efficiency and program impact.

Technology Stack Alignment Existing tech usage (AWS, WordPress, Google Workspace) points to readiness for cloud-based collaboration, data sharing, and secure communications. Propose scalable cloud hosting for research data, compliant collaboration suites, and embeddable outreach platforms to boost global study participation.

Market Positioning As a niche biotech nonprofit focused on LGMD calpainopathy with international reach, C3 can be an anchor client for rare-disease diagnostics, patient registries, and educational content platforms. Target partnerships with rare disease data providers, biobank networks, and advocacy coalitions seeking to expand LGMD2A/R1 and LGMDD4 research impact.

Similar companies to Coalition to Cure Calpain 3

Coalition to Cure Calpain 3 Tech Stack

Coalition to Cure Calpain 3 uses 8 technology products and services including Amazon Web Services, WordPress, Osano, and more. Explore Coalition to Cure Calpain 3's tech stack below.

Media & News

Coalition to Cure Calpain 3's Email Address Formats

Coalition to Cure Calpain 3 uses at least 1 email format:
Coalition to Cure Calpain 3 Email FormatsExamplePercentage
First@curecalpain3.orgJohn@curecalpain3.org
100%

Frequently Asked Questions

What is Coalition to Cure Calpain 3's official website and social media links?

Minus sign iconPlus sign icon
Coalition to Cure Calpain 3's official website is curecalpain3.org and has social profiles on LinkedIn.

How much revenue does Coalition to Cure Calpain 3 generate?

Minus sign iconPlus sign icon
As of September 2026, Coalition to Cure Calpain 3's annual revenue is estimated to be <$1M.

What is Coalition to Cure Calpain 3's SIC code and NAICS code?

Minus sign iconPlus sign icon
Coalition to Cure Calpain 3's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Coalition to Cure Calpain 3 have currently?

Minus sign iconPlus sign icon
As of September 2026, Coalition to Cure Calpain 3 has approximately 3 employees across 1 continents, including North America. Key team members include Medical Doctor: L. W. Explore Coalition to Cure Calpain 3's employee directory with LeadIQ.

What industry does Coalition to Cure Calpain 3 belong to?

Minus sign iconPlus sign icon
Coalition to Cure Calpain 3 operates in the Biotechnology Research industry.

What technology does Coalition to Cure Calpain 3 use?

Minus sign iconPlus sign icon
Coalition to Cure Calpain 3's tech stack includes Amazon Web Services, WordPress, Osano, oEmbed, Google Workspace, Twemoji, Onsen UI and GTranslate.

What is Coalition to Cure Calpain 3's email format?

Minus sign iconPlus sign icon
Coalition to Cure Calpain 3's email format typically follows the pattern of First@curecalpain3.org. Find more Coalition to Cure Calpain 3 email formats with LeadIQ.

When was Coalition to Cure Calpain 3 founded?

Minus sign iconPlus sign icon
Coalition to Cure Calpain 3 was founded in 2010.
Coalition to Cure Calpain 3 logo

Coalition to Cure Calpain 3

Biotechnology ResearchConnecticut, United States2-10 Employees

The Coalition to Cure Calpain 3 (C3) is a biotechnology research organization focused on advancing treatment and potential cures for calpainopathy, including LGMD2A/R1 and LGMDD4. Its work centers on funding research and coordinating clinical trials while educating the global community about this rare muscular dystrophy, with the aim of addressing progressive muscle weakness and wasting associated with the disease.
Based in Westport, Connecticut, C3 operates with a small team and collaborates with partner organizations such as Rare Disorders, Inc. and the National Organization for Rare Disorders (NORD) to reach researchers and patient communities, develop diagnostic codes in collaboration with established groups, and launch studies with broad reach. The organization functions within the biotechnology research sector, positioning itself as a driving force for research funding and strategic partnerships that advance gene therapy and other investigational approaches for LGMD2A/R1 and related conditions.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2010
Employees
2-10

Section iconFunding & Financials

  • <$1M

    Coalition to Cure Calpain 3's revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.